5α-Reductase Inhibitors (5ARIs) and Male Reproduction
January 2017
in “Advances in Experimental Medicine and Biology”
TLDR 5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.
The document from 2017 reviews the effects of 5α-Reductase Inhibitors (5ARIs), specifically finasteride and dutasteride, on male reproduction. These drugs are used to treat benign prostate hyperplasia (BPH) and lower urinary tract symptoms, and at lower doses, they are used to treat male hair loss by inhibiting the conversion of testosterone to dihydrotestosterone (DHT). While testosterone levels remain relatively stable, DHT levels can be reduced by up to 90% in men taking these medications. The document reports that 5ARIs are known to negatively impact libido, erectile function, and ejaculation, with a meta-analysis indicating an odds ratio of ejaculatory dysfunction of 3 for both finasteride and dutasteride. Regarding semen quality, while most men remain within the normal range, some studies have reported a decrease in total sperm count and motility, with a small subset of men experiencing a significant reduction to less than 10% of baseline values. This effect seems to be reversible upon discontinuation of the drug. The lower doses of finasteride used for treating male-pattern baldness appear to have little effect on semen quality in men with normal semen, but there are reports of negative effects on sperm numbers in men with oligozoospermia. The document concludes that while most men taking 5ARIs for BPH will experience only small negative effects on semen quality, some may be profoundly affected, and more studies are needed to assess fertility endpoints in 5ARI-treated men.
View this study on link.springer.com →
Cited in this study
research Characteristics of Men Who Report Persistent Sexual Symptoms After Finasteride Use for Hair Loss
Finasteride for hair loss may cause persistent sexual symptoms, depression, anxiety, and lower quality of life.
research Finasteride, not tamsulosin, increases severity of erectile dysfunction and decreases testosterone levels in men with benign prostatic hyperplasia
Finasteride worsens erectile dysfunction and lowers testosterone in men with enlarged prostates, unlike tamsulosin.
research Spermatozoa and Chronic Treatment with Finasteride: A TEM and FISH Study
Finasteride may negatively affect male fertility.
research The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men
Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.
research Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor
Dutasteride more effectively lowers DHT levels in men with enlarged prostates than finasteride.
research CHRONIC TREATMENT WITH FINASTERIDE DAILY DOES NOT AFFECT SPERMATOGENESIS OR SEMEN PRODUCTION IN YOUNG MEN
Finasteride doesn't harm male fertility or sperm quality, but may slightly reduce ejaculate volume.
research Assessment of the Pharmacokinetic -Pharmacodynamic Interaction Between Terazosin and Finasteride
Terazosin and finasteride together cause no major issues.
Related
research 5α-Reductase Inhibitors (5ARIs) and Male Reproduction
5α-Reductase inhibitors can negatively affect male sexual function and, in some cases, significantly reduce sperm count, but these effects may be reversible.
research The Effect of 5α-Reductase Inhibition with Dutasteride and Finasteride on Semen Parameters and Serum Hormones in Healthy Men
Dutasteride and finasteride may reduce sperm count and volume but don't affect movement or shape; effects are reversible after stopping.